Skip to content

    Pain Management Health Center

    Font Size
    A
    A
    A

    FDA OK's 'Abuse-Deterrent' Label for New Oxycontin

    Latest formulation is tougher to crush and dissolve, making illicit use more difficult

    WebMD News from HealthDay

    By EJ Mundell

    HealthDay Reporter

    TUESDAY, April 16 (HealthDay News) -- In an effort to help curb the epidemic of prescription painkiller abuse, the U.S. Food and Drug Administration on Tuesday said it is approving new labeling for a reformulated version of Oxycontin that its maker claims will be harder to abuse.

    The agency also noted that the original form of the powerful painkiller has been withdrawn from the market because it is easier to abuse than the newer formulation.

    "Accordingly, the agency will not accept or approve any abbreviated new drug applications (generics) that rely upon the approval of original OxyContin," the FDA added in a news release issued late Tuesday.

    Prescription painkiller abuse continues to be a major problem across the United States. According to a report issued in January by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), some 22 million Americans -- 2 percent of the population -- have misused prescription painkillers since 2002.

    Oxycontin (oxycodone hydrochloride controlled-release) already has Schedule II status as a potentially harmful and restricted-access narcotic, based on an FDA review. In January, an agency advisory panel voted to move other hydrocodone-containing painkillers such as Vicodin and Percocet to the same status.

    One other way to rein in rampant abuse of precription narcotics is to develop formulations that are more difficult to break down and abuse.

    The original form of Oxycontin, first approved in 1995, "was abused, often following manipulation intended to defeat its extended-release properties," the FDA explained. "Such manipulation causes the drug to be released more rapidly, which increases the risk of serious adverse events, including overdose and death."

    The new, "abuse-deterrent" version was approved in 2010 after being developed by maker Purdue Pharma, and the company stopped shipments of the older version of Oxycontin to pharmacies in August of that year.

    The new version is "more difficult to crush, break or dissolve," the FDA said, and it forms a thick, sticky gel that resists being used as an injection. It is also more difficult to manipulate the drug so it can be snorted, the agency said.

    Today on WebMD

    pain in brain and nerves
    Top causes and how to find relief.
    knee exercise
    8 exercises for less knee pain.
     
    acupuncture needles in woman's back
    How it helps arthritis, migraines, and dental pain.
    chronic pain
    Get personalized tips to reduce discomfort.
     
    illustration of nerves in hand
    Slideshow
    lumbar spine
    Slideshow
     
    Woman opening window
    Slideshow
    Man holding handful of pills
    Video
     
    Woman shopping for vegetables
    Slideshow
    Sore feet with high heel shoes
    Slideshow
     
    acupuncture needles in woman's back
    Slideshow
    man with a migraine
    Slideshow